Long term outcome of Ph+ CML patients achieving complete cytogenetic remission with interferon based therapy moving from interferon to imatinib era-Reference-Cited by-同舟云学术

Long term outcome of Ph+ CML patients achieving complete cytogenetic remission with interferon based therapy moving from interferon to imatinib era

Published:2014-02 Issue:2 Volume:89 Page:119-124
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Malagola Michele¹,Breccia Massimo²,Skert Cristina¹,Cancelli Valeria¹,Soverini Simona³,Iacobucci Ilaria³,Cattina Federica¹,Liberati Anna Maria⁴,Tiribelli Mario⁵,Annunziata Mario⁶,Trabacchi Elena⁷,De Vivo Antonio³,Castagnetti Fausto³,Martinelli Giovanni³,Fogli Miriam³,Stagno Fabio⁸,Pica Gianmatteo⁹,Iurlo Alessandra¹⁰,Pregno Patrizia¹¹,Abruzzese Elisabetta¹²,Pardini Simonetta¹³,Bocchia Monica¹⁴,Russo Sabina¹⁵,Pierri Ivana¹⁶,Lunghi Monia¹⁷,Barulli Sara¹⁸,Merante Serena¹⁹,Mandelli Franco²⁰,Alimena Giuliana²,Rosti Gianatonio³,Baccarani Michele²¹,Russo Domenico¹

Affiliation:

1. Chair of Haematology, Unit of Blood Diseases and Stem Cell Transplantation; University of Brescia; 25100 Brescia Italy

2. Hematology, Department of Cellular Biotechnologies and Hematology; Sapienza University; Rome Italy

3. Institute of Hematology “L. and A. Seràgnoli”, Department of Experimental, Diagnostic and Specialty Medicine; University of Bologna; Bologna Italy

4. Oncohematology Unit, Department of Clinical and Experimental Medicine; S. Maria Hospital; Terni Italy

5. Division of Hematology and Bone Marrow Transplantation, Department of Experimental and Clinical Medical Sciences; Azienda Ospedaliero Universitaria; Udine Italy

6. Divisione di Ematologia e Trapianto; Ospedale Cardarelli; Napoli Italy

7. Department of Oncology and Hematology; G. da Saliceto Hospital; Piacenza Italy

8. Hematology Section, Department of Clinical and Biomolecular Medicine; Ferrarotto Hospital, University of Catania; Catania Italy

9. Division of Hematology; Azienda Ospedaliera Universitaria San Martino; Genova Italy

10. Hematology and Trasplantation Unit,Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico; Milan Italy

11. Hematology 2, ASO S. Giovanni Battista; Torino Italy

12. Hematology, S. Eugenio Hospital; Rome Italy

13. Istituto di Ematologia, Azienda Ospedaliero-Universitaria; Sassari Italy

14. Unit of Hematology, AOU Senese Policlinico S. Maria alle Scotte; University of Siena; Siena Italy

15. UOC Ematologia, AOU G. Martino Policlinico di Messina; Messina Italy

16. Dipartimento di terapie oncologiche integrate; IRCCS AOU S. Martino-IST Genova; Genova Italy

17. Division of Hemathology, Department of Translational Medicine; Amedeo Avogadro University of Eastern Piedmont; Novara Italy

18. UO di Ematologia e Centro Trapianti Midollo Osseo; Azienda Ospedaliera Ospedali Riuniti Marche Nord; Pesaro Italy

19. Division of Hematology, Department of Oncohematology; IRCCS Fondazione Policlinico San Matteo; Pavia Italy

20. GIMEMA Data Center; Rome Italy

21. Department of Hematology-Oncology “L. and A. Seràgnoli”; University of Bologna; Bologna Italy

Publisher

Wiley

Subject

Hematology

Reference39 articles.

1. Interferon alpha for treatment of chronic myeloid leukemia;Simonsson;Curr Drug Targets,2011

2. Interferon in chronic myeloid leukaemia: Past and future;Guilhot;Best Pract Res Clin Haematol,2009

3. Interferon-alfa for chronic myeloid leukemia;Baccarani;Semin Hematol,2003

4. Re-emergence of interferon-α in the treatment of chronic myeloid leukemia;Talpaz;Leukemia,2013

5. Italian Cooperative Study Group on Myeloid Leukemia. A randomized study of interferon-alpha versus interferon-alpha and low-dose arabinosyl cytosine in chronic myeloid leukemia;Baccarani;Blood,2002

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Control of Ph+ and additional chromosomal abnormalities in chronic myeloid leukemia by tyrosine kinase inhibitors;Medical Oncology;2023-07-13

2. Chronic Myeloid Leukemia and Pregnancy: When Dreams Meet Reality. State of the Art, Management and Outcome of 41 Cases, Nilotinib Placental Transfer;Journal of Clinical Medicine;2022-03-24

3. Development of BCR-ABL1 Transgenic Zebrafish Model Reproducing Chronic Myeloid Leukemia (CML) Like-Disease and Providing a New Insight into CML Mechanisms;Cells;2021-02-19

4. The Interferon-Alpha Revival in CML;Hematologic Malignancies;2021

5. Achievements and Challenges in Allogeneic Hematopoietic Stem Cell Transplantation in Cytogenetically Unfavorable Acute Leukemias (Literature Review);Clinical oncohematology;2019